<?xml version="1.0" encoding="UTF-8"?>
<p id="para0029">Ribavirin is a nucleoside analogue with broad antiviral activity. It can prevent the replication of RNA and DNA viruses by suppressing the activity of inosine monophosphate dehydrogenase, which is required for the synthesis of guanosine triphosphate (GTP). Ribavirin was widely used to treat SARS patients with or without concomitant use of steroids during the outbreak of SARS in Hong Kong 
 <xref rid="bib0074" ref-type="bibr">[74]</xref>, 
 <xref rid="bib0075" ref-type="bibr">[75]</xref>, 
 <xref rid="bib0076" ref-type="bibr">[76]</xref>. Thus, ribavirin could be considered as a treatment option for COVID-19 patients.
</p>
